National Conference on CVD Prevention at Guwahati, Assam
Date: 18th - 20th Oct , 2019 | Venue: Radisson Blu, Guwahati, Assam
Kindly note that participants registered with PHFI courses will get a 50% discount on registration fee.
Incidence of Cardiovascular Disease (CVD) is increasing at an alarming rate in India and other South East Asian countries. A huge chunk of national and personal income is spent on treatment costs. Hence Prevention of CVD is of great importance in a developing country like India. The CSI Preventive Council conducts a national conference on Prevention of CVD every two years to help physicians understand and address this issue. This year the conference is been held in the beautiful city of Guwahati, the Gateway to the North East.
On behalf of the organizing committee, it gives us immense pleasure to invite you for this conference being held from 18th to 20th October, 2019. The scientific agenda has been prepared in a unique way to make it interesting in the form of case discussions, interactive sessions, debates and workshops. The theme of the conference is “Translating Evidence into Practice”.
Assam particularly is known for its world famous Tea and Muga Silk. The mighty Brahmaputra flows through the city while the smallest inhabited river island, Umananda can be seen from the city itself. A large number of visitors to Guwahati come only to see the Kamakhya Temple one of the most important Shakti Peeth of the country.
The organizing committee welcomes you to enjoy the hospitality of the northeast, participate in the scientific feast and make the conference a huge success.
PHFI participated in South East Asia Diabetes Federation Conference 2017 held on 4th and 5th November 2017 for advocacy of our various capacity building initiatives including the Thyroid Training Programme.
PHFI was represented by Dr. Sandeep Bhalla and Dr. Deepak Monga in the conference. The theme of the conference was “Quality diabetic care beyond sociocultural barriers”. It was attended by over 500 delegates and had a representation from all South East Asian countries.
PHFI had its own stall in the conference which was utilized for the advocacy of our various capacity building initiatives. The delegates who visited the stall were apprised regarding the various activities done at PHFI as well as the capacity building initiatives in chronic conditions that are being successfully implemented in India. Dr. Bhalla also had a session on 5th November on ‘PHFI and its work in Public health Arena with special focus on capacity building’. The course brochure for Nepal was also released during the inauguration of the conference.
PHFI participated in the 87th Annual Meeting of the American Thyroid Association in Victoria BC, Canada from 18th to 22nd October 2017 for advocacy of our various capacity building initiatives including the Thyroid Training Programme.
ATA 87th Annual Meeting was attended by over 1100 delegates from different parts of the World. The meeting of the ATA aimed to update the community of endocrinologists, internists, surgeons, basic scientists, nuclear medicine scientists, pathologists, trainees, nurses, physician assistants and other health care professionals who wish to broaden and update their knowledge of the thyroid gland and its disorders. Dr. Pushkar Kumar, Dr. Deepak Monga and Mr. Alex I represented PHFI on this prestigious platform. PHFI had a stall during the event which was utilized for the advocacy of the various capacity building initiatives in chronic conditions done by PHFI. Delegates from around the world expressed keen interest in the course and discussed modalities of its implementation to adapt the course for their respective countries. A poster of Dr. Pushkar titled “Evaluation and Quality Assurance of Effectiveness of an AOTA Recognized Thyroid Training Programme for Primary Care Physicians in India” was selected for the poster presentation during the conference. Dr. Pushkar & Dr. Deepak were also invited to represent PHFI at American Thyroid Association Corporate Leadership Council Meeting held on 21st October wherein they briefed the ATA Board members and other partners regarding PHFI’s work and the capacity building initiative in the management of thyroid course (CCMTD).